On assessing risks of developing and progressing non-alcoholic fatty liver disease using TNF-α, IL6, and VEGF factors and polymorphisms of their genes

On assessing risks of developing and progressing non-alcoholic fatty liver disease using TNF-α, IL6, and VEGF factors and polymorphisms of their genes

Our research aim was to develop a system for calculating risks of development and progression of non-alcoholic fatty liver disease (NAFLD). The system would be based on interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), vascular endothelial growth factor (VEGF) and TNF-α gene polymorphism in...

Full description

Bibliographic Details
Main Authors: I.A. Bulatova, L.D. Pestrenin, T.P. Shevlyukova, A.V. Krivtsov, I.L. Gulyaeva
Format: Article
Language:English
Published: FBSI “Federal Scientific Center for Medical and Preventive Health Risk Management Technologies” 2022-03-01
Series:Analiz Riska Zdorovʹû
Subjects:
non-alcoholic fatty liver disease
cytokines
tumor necrosis factor alpha
interleukin-6
vascular endothelial growth factor
gene polymorphism
Online Access:https://journal.fcrisk.ru/eng/2022/1/12

Similar Items

Similar Items